Autoimmune Progesterone Dermatitis With Angioedema Caused by Exogenous Progesterone in a Pregnant Woman: A Case Report

Authors

1 Department of Emergency Medicine, Mashhad University of Medical Sciences, Mashhad, IR Iran

2 Department of Psychiatry, Tabriz University of Medical Sciences, Tabriz, IR Iran

3 Honorary Fellow Research, Aberdeen Biomedical Imaging Centre, Aberdeen University, Aberdeen, UK

Abstract

Introduction: Autoimmune progesterone dermatitis (APD) is an uncommon immunologic condition accompanied with dermatologic manifestations and caused by an immune response to endogenous or exogenous progesterone in women during their reproductive years. We report a case of APD in a pregnant woman who received exogenous progesterone to prevent preterm delivery. Case Presentation: A 28-year-old female who was 17 weeks pregnant was referred to the emergency department with the complaint of progressive edema in the dorsal side of her right hand and progressive dyspnea. Intradermal skin test using 50 mg/mL progesterone resulted in 15 mm wheal in the injected area and approved the diagnosis of APD. Conclusions: Patients with APD may have very different symptoms requiring immediate care; therefore, being informed about this condition is necessary for the physicians in emergency and obstetrics and gynecology departments. Also a positive history of such condition in a pregnant woman necessitates precautions in the management of her pregnancy due to the potential of anaphylactic events.

Keywords

References

  1. Géber H. Some information about the pathology of urticaria menstruationalis, [in German]. Dermatology. 1921;32(2-3):143–50.
  2. Baptist AP, Baldwin JL. Autoimmune progesterone dermatitis in a patient with endometriosis: case report and review of the literature. Clin Mol Allergy. 2004;2(1):10.
  3. Snyder JL, Krishnaswamy G. Autoimmune progesterone dermatitis and its manifestation as anaphylaxis: a case report and literature review. Ann Allergy Asthma Immunol. 2003;90(5):469–77. 4. Bolaji ,I, O'Dwyer EM. Post-menopausal cyclic eruptions: autoimmune progesterone dermatitis. Eur J Obstet Gynecol Reprod Biol. 1992;47(2):169–71.
  4. Brooks GG. Anaphylactoid shock with medroxyprogesterone acetate: A case report. J La State Med Soc. 1974;126(11):397–9.
  5. Meggs WJ, Pescovitz OH, Metcalfe D, Loriaux DL, Cutler GBJ, Kaliner M. Progesterone Sensitivity as a Cause of Recurrent Anaphylaxis. Obstet Gynecol Surv. 1985;40(6):372–3.
  6. Slater J, Kaliner M. Effects of sex hormones on basophil histamine release in recurrent idiopathic anaphylaxis. J Allergy Clin Immunol. 1987;80(3):285–90.
  7. Slater JE, Raphael G, Cutler GJ, Loriaux DL, Meggs WJ, Kaliner M. Recurrent anaphylaxis in menstruating women: treatment with a luteinizing hormone-releasing hormone agonist--a preliminary report. Obstet Gynecol. 1987;70(4):542–6.
  8. Bandino JP, Thoppil J, Kennedy JS, Hivnor CM. Iatrogenic autoimmune progesterone dermatitis caused by 17alpha-hydroxyprogesterone caproate for preterm labor prevention. Cutis. 2011;88(5):241–3.
  9. Warin AP. Case 2. Diagnosis: erythema multiforme as a presentation of autoimmune progesterone dermatitis. Clin Exp Dermatol. 2001;26(1):107–8.
  10. Kakarla N, Zurawin RK. A case of autoimmune progesterone dermatitis in an adolescent female. J Pediatr Adolesc Gynecol. 2006;19(2):125–9.
  11. Dedecker F, Graesslin O, Quereux C, Gabriel R, Salmon-Ehr V. Autoimmune progesterone dermatitis: a rare pathology. Eur J Obstet Gynecol Reprod Biol. 2005;123(1):120–1.
  12. Jenkins J, Geng A, Robinson-Bostom L. Autoimmune progesterone dermatitis associated with infertility treatment. J Am Acad Dermatol. 2008;58(2):353–5.
  13. Rodenas JM, Herranz MT, Tercedor J. Autoimmune progesterone dermatitis: treatment with oophorectomy. Br J Dermatol. 1998;139(3):508–11.
  14. Schoenmakers A, Vermorken A, Degreef H, Dooms-Goossens A. Corticosteroid or steroid allergy? Contact Dermatitis. 1992;26(3):159–62.
  15. Meltzer L. Hypersensitivity to gonadal hormones. South Med J. 1963;56:538–42.
  16. George R, Badawy SZ. Autoimmune progesterone dermatitis: a case report. Case Rep Obstet Gynecol. 2012;2012:757854.
  17. Bierman SM. Autoimmune progesterone dermatitis of pregnancy. Arch Dermatol. 1973;107(6):896–901.
  18. Farah FS, Shbaklu Z. Autoimmune progesterone urticaria. J Allergy Clin Immunol. 1971;48(5):257–61.
  19. Georgouras K. Autoimmune progesterone dermatitis. Australas J Salari Rad M et al. 32 Razavi Int J Med. 2015;3(3):e29765 Dermatol. 1981;22(3):109–12.
  20. Leech SH, Kumar P. Cyclic urticaria. Ann Allergy. 1981;46(4):201–3.
  21. Hart R. Autoimmune progesterone dermatitis. Arch Dermatol. 1977;113(4):426–30.
  22. Brestel E, Thrush L. The treatment of glucocorticosteroid-dependent chronic urticaria with stanozolol. J Allergy Clin Immunol. 1988;82(2):265–9.
  23. Shahar E, Bergman R, Pollack S. Autoimmune progesterone dermatitis: effective prophylactic treatment with danazol. Int J Dermatol. 1997;36(9):708–11.
Razavi International Journal of Medicine
Volume 3, Issue 3
July 2015
Pages 1-4

Files

Share

How to cite

Statistics